Trade
Thyrocare Technologies share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹530.00(-2.16%)July 15, 2026 15:29:47 PM IST
- NSE
- BSE
- Vol : 372.28 K (NSE + BSE)Last 20 day avg : 381.25 K
Thyrocare Technologies is trading -2.16% lower at Rs 530.00 as compared to its last closing price. Thyrocare Technologies has been trading in the price range of 547.05 & 527.75. Thyrocare Technologies has given 21.26% in this year & 1.59% in the last 5 days. Thyrocare Technologies has TTM P/E ratio 34.09 as compared to the sector P/E of 27.37.There are 5 analysts who have initiated coverage on Thyrocare Technologies. There are 3 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 47.11 Crores in its last quarter.Listed peers of Thyrocare Technologies include Fortis Healthcare (0.82%), Global Health (1.70%), Narayana Hrudayalaya (1.43%).The Mutual Fund holding in Thyrocare Technologies was at 19.86% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Thyrocare Technologies was at 5.43% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 15, 2026, 08:19 PM UTC
- BetaLow volatility0.79Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.09The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.73Annual dividends as a percentage of the stock price.
- P/BHigher than historical values14.69The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values52.90Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates Fair Valuation1.46The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Thyrocare Technologies News
Thyrocare Technologies Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Fortis Healthcare | 977.80 | 0.82 | 72,740.22 | 80.04 | 7.64 | 0.11 | 25.92 |
| Global Health | 1,343.20 | 1.70 | 36,015.33 | 61.73 | 9.45 | 0.04 | 18.41 |
| Narayana Hrudayalaya | 2,038.00 | 1.43 | 41,486.65 | 47.66 | 10.51 | 0.24 | 59.03 |
| Max Healthcare Institute | 1,107.75 | 1.46 | 1,07,814.36 | 93.43 | 11.21 | 0.14 | 29.50 |
| Apollo Hospitals Enterprise | 8,933.85 | 0.37 | 1,28,312.34 | 71.09 | 12.56 | 0.26 | 83.18 |
Mutual Fund Ownership
View allThyrocare Technologies Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-14 | Qtr Results, Int. Dividend & Bonus issue |
| 2025-07-23 | Quarterly Results |
| 2025-04-23 | Audited Results & Final Dividend |
About the company Thyrocare Technologies
- IndustryHealthcare Facilities
- ISININE594H01019
- BSE Code539871
- NSE CodeTHYROCARE
Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It offers a range of diagnostic and related healthcare tests and services that are focused on early detection, preventive care, and ongoing disease monitoring. Its segments include diagnostic testing services, Imaging Services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services include diagnostic and imaging services, the selling of radiopharmaceuticals, and consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and the selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, and a medical cyclotron facility across India. It is also focused on offering pathological services.
Thyrocare Technologies Share Price FAQs
Thyrocare Technologies is trading at 530.00 as on Wed Jul 15 2026 09:59:47. This is -2.16% lower as compared to its previous closing price of 541.70.
The market capitalization of Thyrocare Technologies is 8488.26 Cr as on Wed Jul 15 2026 09:59:47.
The average broker rating on Thyrocare Technologies is Strong Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Thyrocare Technologies is 578.05 whereas the 52 wk low is 342.55
Thyrocare Technologies can be analyzed on the following key metrics -
- TTM P/E: 34.09
- Sector P/E: 27.37
- Dividend Yield: 1.73%
- D/E ratio: 0.09
Thyrocare Technologies reported a net profit of 163.04 Cr in 2026.
The Mutual Fund Shareholding was 19.86% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Thyrocare Technologies QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.